Ascendis Pharma Stock (ASND) Soars 7% on a Settlement with BioMarin Pharmaceutical (BMRN)
Ascendis Pharma stock rallied 7% on Monday after the company reached a global settlement and license deal with BioMarin Pharmaceutical.
Biomarin Pharmaceutical Inc (BMRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 7,616,563 | $435,819,735 | +8% | 1.24% |
| 2. | Vestal Point Capital Ryan Wilder | 6,025,000 | $344,750,500 | +69% | 8.06% |
| 3. | AQR Capital Management Cliff Asness | 5,699,541 | $322,537,038 | -26% | 0.11% |
| 4. | Deep Track Capital David Kroin | 3,307,481 | $189,254,063 | +188% | 2.75% |
| 5. | Millennium Management Israel Englander | 2,071,816 | $118,549,312 | -32% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.75 | 3,625 | $314,468.75 | 10,905 | 2022-10-31 | Filing | |
| $78.84 | 900 | $70,955.37 | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | $930,759.69 | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | $3,503.36 | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | $11,924.48 | 15,294 | 2012-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.85 | 3,281 | $176,681.85 | 51,818 | 2026-05-07 | Filing | |
| $60.46 | 16,486 | $996,743.56 | 79,953 | 2026-03-11 | Filing | |
| $60.38 | 6,326 | $381,937.31 | 37,578 | 2026-02-26 | Filing | |
| $61.36 | 26,061 | $1,599,102.96 | 72,453 | 2026-02-26 | Filing | |
| $59.31 | 1,786 | $105,927.66 | 14,173 | 2025-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,445,212 | $1,169,875,004 | 0.02% | |
| 2. | 14,844,930 | $849,426,895 | 0.44% | |
| 3. | 14,190,183 | $811,962,329 | 0.48% | |
| 4. | 8,743,633 | $500,310,680 | 0.01% | |
| 5. | 8,648,678 | $494,877,355 | 0.02% |
News See All
BioMarin Pharmaceutical (BMRN)'s Alesta Deal Adds New Growth Potential in Rare Diseases
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is expanding its rare-disease business with the acquisition of Alesta Therapeutics for $275 million upfront.
Q2 Earnings Blowouts: 37 Stocks That Beat Expectations
The ongoing earnings season has been a boon to listed companies' share prices in the second quarter of the year, helping offset macroeconomic uncertainties such as the US-Iran war, global trade, and questions...
10 Most Promising Stocks with Highest Upside Potential
In this article, we will discuss the 10 Most Promising Stocks with Highest Upside Potential.
10 Most Undervalued Stocks to Buy and Hold for 2 Years
In this article, we will discuss the 10 Most Undervalued Stocks to Buy and Hold for 2 Years.
8 Stocks That Could 10X by 2030
In this article, we will discuss the 8 Stocks That Could 10X by 2030.
10 Best Low Priced Stocks to Buy for the Next 3 Years
In this article, we will discuss the 10 Best Low Priced Stocks to Buy for the Next 3 Years.
Evercore ISI Lifts PT on BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best healthcare stocks to buy for the long term. Evercore ISI lifted the price target on BioMarin Pharmaceutical Inc.
10 Best Healthcare Stocks to Buy for the Long Term
In this article, we will look at the 10 Best Healthcare Stocks to Buy for the Long Term.
Is BioMarin Pharmaceutical Inc. (BMRN) One of the Top Cheap Stocks to Buy With the Biggest Upside Potential?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top cheap stocks to buy with the biggest upside potential. BioMarin Pharmaceutical Inc.
Hedge Fund Resource Center